İbrahim Halil YAVUZ, Göknur Özaydın YAVUZ, Serap Güneş BİLGİLİ, Kubra TATAR, Irfan BAYRAM

Evaluation of 62 bullous pemphigoid patients

Bullous pemphigoid (BP) is an acquired autoimmune disease often manifesting with subepidermal bullae. Autoantibodies against hemidesmosomes constitute the main cause of BP. In this study, we aimed to evaluate the clinical and histopathological characteristics of BP patients and to discuss them in light of the studies conducted in Turkey and around the world. The retrospective study included 62 patients that were diagnosed with BP in our clinic between 2005 and 2017. Diagnosis of BP was established based on clinical, histopathological, and DIF microscopy findings. Age, gender, duration of disease, presence of pruritus, peripheral eosinophilia, significant histopathological findings, history of smoking, and family history were recorded for each patient. Patients under 18 years of age were excluded from the study. The 62 patients comprised 24 (38.7%) men and 38 (61.3%) women with a median age of 72.0 years. The male-to-female ratio was 1.5. The median age at disease onset was 67.0 (range, 50-75) years and the median duration of disease was 1.0 (0.5-3.0) years. Of the 62 patients, 35 (56.5%) had a history of smoking and mucosal involvement was found in 27 (43.5%) patients. BP is a disease of the elderly and more common in women than in men. Oral mucosa should be an integral part of the physical examination in BP patients. Pruritus is a significant clinical symptom and eosinophilia is an important laboratory marker in the diagnosis of BP, particularly in patients with difficult diagnosis.

PDF

___

Banihashemi M, Zabolinejad N, Vahabi Set al. Survey of bullous pemphigoid disease in northern Iran. Int J Dermatol. 2015;54:1246-9.

Bağcı IS, Horváth ON, Ruzicka T, et al. Bullous pemphigoid. Autoimmun Rev. 2017;16:445-55.

Bernard P, Antonicelli F. Bullous pemphigoid: A review of its diagnosis, associations and treatment. Am J Clin Dermatol. 2017;18:513-28.

Joly P, Baricault S, Sparsa A, et al. Incidence and mortality of bullous pemphigoid in France. J Invest Dermatol. 2012;132:1998-2004.

Försti AK, Jokelainen J, Timonen M, et al. Increasing incidence of bullous pemphigoid in Northern Finland: a retrospective database study in Oulu University Hospital. Br J Dermatol. 2014;171:1223-6.

Marazza G, Pham HC, Schärer L, et al. Autoimmune bullous disease Swiss study group. Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study. Br J Dermatol. 2009;161:861-8.

Colbert RL, Allen DM, Eastwood D, et al. Mortality rate of bullous pemphigoid in a US medical center. J Invest Dermatol. 2004;122:1091-5.

Nanda A, Al-Saeid K, Al-Sabah H, et al. Clinicoepidemiological features and course of 43 cases of bullous pemphigoid in Kuwait. Clin Exp Dermatol. 2006;31:339-42.

Akay BN, Bodamyalı P, Şanlı H, et al. Büllöz pemfigoidli hastalarda 10 yıllık gözlem. Turkderm. 2010;44:61-4.

Ekiz Ö, Bülbül Şen B, Rifaioğlu EN, et al. Büllöz pemfigoidli hastalarda 3 yıllık gözlem: 29 olgu. Turkderm. 2013;47:205-8.

Esmaili N, Hallaji Z, Soori T, et al. Bullous pemphigoid in Iranian patients: a descriptive study on 122 cases. Acta Med Iran. 2012;50:335-8.

Yazıcı S, Başkan EB, Tunalı Ş, et al. Retrospective analysis of forty-six patients with bullous pemphigoid followed-up in our clinic. Turkderm. 2016;50:114-8.

Chang YT, Liu HN, Wong CK. Bullous pemphigoid: a report of 86 cases from Taiwan. Clin Exp Dermatol. 1996;21:20-2.

Kızılyel O, Elmas ÖF, Bilen H, et al. Bullous pemphigoid in Erzurum:A 10 year retrospective study. Turkderm. 2015;49:66-9.

Akarsu S, Özbağçivan Ö, Dolaş N, et al. Possible triggering factors and comorbidities in newly diagnosed autoimmune bullous diseases. Turk J Med Sci. 2017;47:832-40.

Alexandre M, Brette MD, Pascal F, et al. A prospective study of upper aerodigestive tract manifestations of mucous membrane pemphigoid. Medicine (Baltimore). 2006;85:239-52.

Sobhan M, Farshchian M, Tamimi M. Spectrum of autoimmune vesiculobullous diseases in Iran: a 13-year retrospective study. Clin Cosmet Investig Dermatol.2016;9:15-20.

Kibsgaard L, Bay B, Deleuran M, et al. A retrospective consecutive caseseries study on the effect of systemic treatment, length of admission time, and co-morbidities in 98 bullous pemphigoid patients admitted to a tertiary centre. Acta Derm Venereol. 2015;95:307-11.

Lo Schiavo A, Ruocco E, Brancaccio G, et al. etiology, pathogenesis, and inducing factors: facts andcontroversies. Clin Dermatol. 2013;31:391-99.

Daye M, Mevlitoğlu İ, Esener S. Bullous disorders in Konya: A study of 93 cases: Turkderm. 2013;47:200-4.